Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Nippon Chemical Industrial Co., Ltd. is currently managing 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 3 distinct examiners, indicating that each active case is being reviewed by a different official. However, all 3 pending office actions are concentrated within 1 distinct art unit, suggesting a narrow administrative focus despite the multiple examiners involved. This concentration implies that the company's pharmaceutical innovations are being evaluated against a consistent set of internal standards.
The busiest examiner for the company is HOBAN, MATTHEW E, who is responsible for 1 busiest examiner pending office action. Since there are pending office actions in total, the workload is distributed among the 3 distinct examiners. The concentration within 1 distinct art unit means that the company's prosecution strategy is tied to the prior art databases used by that specific unit, which may streamline the process across different cases. Practitioners should note that HOBAN, MATTHEW E is one of the officials managing the active docket.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOBAN, MATTHEW E | 1 | 60.4% | +25.3% |
| GODENSCHWAGER, PETER F | 1 | 68.0% | +17.7% |
| PAGANO, ALEXANDER R | 1 | 78.7% | +11.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681608 | METHOD FOR PRODUCING QUANTUM DOT | GODENSCHWAGER, PETER F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18842482 | METHOD FOR PRODUCING QUANTUM DOT | HOBAN, MATTHEW E | — |
| 18681608 | METHOD FOR PRODUCING QUANTUM DOT | GODENSCHWAGER, PETER F | — |
| 17058221 | METHOD FOR PRODUCING PHOSPHINOBENZENE BORANE DERIVATIVE, METHOD FOR PRODUCING 1,2-BIS(DIALKYLPHOSPHINO)BENZENE DERIVATIVE, AND TRANSITION METAL COMPLEX | PAGANO, ALEXANDER R | — |
| Art Unit | Apps |
|---|---|
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18842482 | METHOD FOR PRODUCING QUANTUM DOT | HOBAN, MATTHEW E | — | §103 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18681608 | METHOD FOR PRODUCING QUANTUM DOT | GODENSCHWAGER, PETER F | — | §102§112 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 17058221 | METHOD FOR PRODUCING PHOSPHINOBENZENE BORANE DERIVATIVE, METHOD FOR PRODUCING 1,2-BIS(DIALKYLPHOSPHINO)BENZENE DERIVATIVE, AND TRANSITION METAL COMPLEX | PAGANO, ALEXANDER R | 1692 | §103 | Final Rejection | — | Pending | Nov 24, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial